气动雾化器市场规模、份额和成长分析（按适应症、最终用途和地区）- 产业预测 2025-2032

气动雾化器市场规模预计将在 2023 年达到 8.0405 亿美元，从 2024 年的 8.5792 亿美元增长到 2032 年的 14.4133 亿美元，预测期内（2025-2032 年）的复合年增长率为 6.7%。

气动雾化器市场是医疗设备产业的关键组成部分，专注于满足患者的呼吸照护需求。这些设备将液体药物转化为可供吸入的细雾，增强了对气喘和慢性阻塞性肺病等呼吸系统疾病的有效治疗。由于这些疾病的盛行率不断上升、人口老化以及人们对呼吸健康管理的认识不断提高，市场正在稳步增长。此外，技术的进步导致了携带式、易于使用的雾化器的出现，进一步刺激了需求。北美和欧洲引领市场，而亚太地区由于空气污染和医疗保健投资的增加正在迅速扩张。飞利浦伟康和Omron Healthcare等主要企业正在进行创新，以改善患者舒适度和药物输送，确保市场持续成长。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 宏观经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管格局
• 专利分析

气动雾化器市场规模（依适应症划分）

• 市场概况
• 呼吸激活
• 通风

气动雾化器市场规模（依最终用途划分）

• 市场概况
• 医院和诊所
• 家庭医疗保健

气动雾化器市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Philips Healthcare（Netherlands）
• Omron Healthcare, Inc.（Japan）
• PARI GmbH（Germany）
• Drive DeVilbiss Healthcare（USA）
• Medline Industries, Inc.（USA）
• Invacare Corporation（USA）
• GF Health Products, Inc.（USA）
• Briggs Healthcare（USA）
• Allied Healthcare Products, Inc.（USA）
• Aerogen（Ireland）
• Trudell Medical International（Canada）
• Salter Labs（USA）
• Vyaire Medical, Inc.（USA）
• Besco Medical Co., Ltd.（China）
• Rossmax International Ltd.（Taiwan）
• Microlife Corporation（Taiwan）
• Becton, Dickinson and Company（USA）
• Teleflex Incorporated（USA）
• Agilent Technologies, Inc.（USA）
• ResMed Inc.（USA）

结论和建议

Pneumatic Nebulizers Market size was valued at USD 804.05 million in 2023 and is poised to grow from USD 857.92 million in 2024 to USD 1441.33 million by 2032, growing at a CAGR of 6.7% during the forecast period (2025-2032).

The pneumatic nebulizers market is a vital component of the medical devices industry, focused on meeting the respiratory care needs of patients. These devices transform liquid medications into a fine mist for inhalation, enhancing the effective delivery of treatments for respiratory conditions like asthma and COPD. The market is experiencing steady growth due to the increasing incidence of such diseases, an aging population, and heightened awareness regarding respiratory health management. Technological advancements have also led to the emergence of portable and user-friendly nebulizers, further driving demand. North America and Europe lead the market, while the Asia-Pacific region is rapidly expanding due to rising air pollution and healthcare investments. Key players, including Philips Respironics and Omron Healthcare, are innovating to improve patient comfort and medication delivery, ensuring the market's continued growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Pneumatic Nebulizers market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Pneumatic Nebulizers Market Segments Analysis

Global Pneumatic Nebulizers Market is segmented by Indication, End Use and region. Based on Indication, the market is segmented into Breath-Actuated and Vented. Based on End Use, the market is segmented into Hospitals & Clinics and Home Healthcare. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Pneumatic Nebulizers Market

The rising incidence of respiratory ailments such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis significantly propels the growth of the pneumatic nebulizers market. As these conditions demand efficient medication administration directly to the lungs to aid in symptom relief and disease management, there is an escalating need for advanced nebulizer systems. This trend highlights the vital role pneumatic nebulizers play in providing effective therapy for patients suffering from these chronic respiratory illnesses, thereby driving further innovation and investment in this market segment to meet the growing healthcare demands and improve patient outcomes.

Restraints in the Pneumatic Nebulizers Market

The Pneumatic Nebulizers market encounters significant restraints due to the competition posed by alternative respiratory therapies like inhalers and dry powder inhalers. These alternative devices offer convenience, portability, and ease of use, potentially making them more appealing to patients and healthcare providers. As these options continue to gain popularity, they may hinder the growth of the Pneumatic Nebulizers market. Additionally, advancements in inhaler technology and the increasing emphasis on patient-centric treatment approaches can further challenge the market's expansion. Consequently, the presence of these alternative therapies necessitates a strategic response from Pneumatic Nebulizer manufacturers to maintain their market share.

Market Trends of the Pneumatic Nebulizers Market

The pneumatic nebulizers market is experiencing significant growth driven by notable technological advancements that enhance device efficiency and user experience. Innovations such as quieter operation, accelerated drug delivery times, and optimized particle size distribution are becoming increasingly prevalent, facilitating better therapeutic outcomes for respiratory patients. Manufacturers are focusing on user-friendly designs that cater to diverse patient needs, thereby boosting adoption rates among both healthcare professionals and consumers. As awareness of respiratory conditions grows and the demand for effective treatment solutions increases, the pneumatic nebulizers market is positioned for robust expansion, reflecting broader trends towards improved patient-centric healthcare devices.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global Pneumatic Nebulizers Market Size by Indication & CAGR (2025-2032)

• Market Overview
• Breath-Actuated
• Vented

Global Pneumatic Nebulizers Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Hospitals & Clinics
• Home Healthcare

Global Pneumatic Nebulizers Market Size & CAGR (2025-2032)

• North America (Indication, End Use)
  • US
  • Canada
• Europe (Indication, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Indication, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Indication, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Indication, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Omron Healthcare, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PARI GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Drive DeVilbiss Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medline Industries, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Invacare Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GF Health Products, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Briggs Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allied Healthcare Products, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aerogen (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trudell Medical International (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Salter Labs (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vyaire Medical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Besco Medical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rossmax International Ltd. (Taiwan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Microlife Corporation (Taiwan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teleflex Incorporated (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ResMed Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations